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Summary
Peroxidase, H202, and a halide form a powerful antimicrobial system in phagocytes and tissue
fluids, and certain microorganisms can serve as the source of H202 for this system. H202-
generating Lactobacillus acidophilus (LB') is present in the vagina of most normal women and
peroxidase has been detected in vaginal fluid. LB' at high concentration is viricidal to HIV1,
and, at levels where LB' is ineffective alone, the addition of peroxidase (myeloperoxidase,
eosinophil peroxidase) and a halide (chloride, iodide, bromide, thiocyanate) restore viricidal activity.
LB+ can be replaced by H202, but not by non-H202-producing LB, and viricidal activity is
inhibited by azide and catalase. The survival of HIV in the female genital tract and thus the
likelihood of transmission may be influenced by the activity of the LB +-peroxidase-halide system
in the vagina.
H
eterosexual transmission of HIV is occurring with in-
creasing frequency in the United States (1) and remains
the most prevalent mode of transmission in Africa (2, 3).
In heterosexual transmission, HIV released into the vagina
by either partner survives the local defense mechanisms to
infect sexual partners. However, the efficiencyof sexual trans-
mission is extremely variable, suggesting that there may be
factors that can affect the survival of HIV in the vagina.
Peroxidases, when combined with H202 and a halide,
form a powerful antimicrobial system which is effective against
a variety of microorganisms (4), including viruses (5). Mam-
malian peroxidases effective in this way include myeloperoxi-
dase (MPO) present in neutrophils and monocytes, eosino-
phil peroxidase (EPO) in eosinophils, and lactoperoxidase
(LPO) in milk and saliva. A peroxidase with antimicrobial
(6) and spermicidal (7) properties is also present in the uterine
fluid of estrogen-primed rats. Although peroxidases are gener-
ally effective with several halides, the physiologic halide for
MPO is believed to be chloride (4), for EPO bromide (8,
9) or the pseudohalide thiocyanate (10), and for LPO thiocy-
anate (11, 12). The source of H202 for the peroxidase-
mediated antimicrobial system includes the respiratory burst
of stimulated phagocytes and the metabolism of certain
bacteria.
Bacteria designated as lactic acid bacteria, e.g., lactobacilli,
streptococci and pneumococci, release H202 (13) which can
be autoinhibitory (13) and, when mixed cultures are employed,
can be toxic to other bacteria (6, 14), fungi(14), viruses (15),
spermatozoa (16), or tumor cells (17), particularly in the pres-
ence of peroxidase and a halide. The ability of lactobacilli
to provide H202 for a peroxidase-dependent cidal system is
pertinent to the female genital tract, since the predominant
bacterial species in normal human vaginal secretions is Lac-
tobacillus acidophilus, and the vaginal overgrowth ofa number
of organisms in bacterial vaginosis is associated with a de-
crease in H202-generating lactobacilli (18). Thus, the pro-
duction of H202 by lactobacilli in the vigina appears to be
a nonspecific host defense mechanism which can be poten-
tiated by peroxidases of leukocytic or uterine origin. In this
study, we demonstrate the viricidal effect of the peroxidase-
H202-halide system on HIV, and the ability of H202-gen-
erating lactobacilli to provide the H202 required for this
effect.
Materials and Methods
Human Immunodeficiency Virus.
￿
HIV-1 (strain LAV1 kindly
provided by Genetic Systems, Seattle, WA) was propagated in CEM
cells (kindly provided by Genetic Systems) in CEM growth medium
(RPMI-1640 [Gibco Laboratories, Grand Island, NY] containing
10% FetalBovine Serum [Gibco Laboratories], 50 U/ml penicillin,
50 mcg/ml streptomycin, 0.01% DEAF Dextran [500,000 Mr;
Sigma Chemical Co., St. Louis, MO], and 0.01 M Hepes buffer,
pH 6.8) . HIV in the cell supernatant was diluted to 106 tissue cul-
ture infective dose 50 (TCIDso)/ml in CEM growth medium and
frozen in liquid nitrogen gas phase. Stock virus was diluted 100-
fold with 0.1 M sodium sulfate priorto a further 10-fold dilution
in the reaction mixture (final concentration, 1000 TCIDso/ml). In
addition to the components listed, the reaction mixture contained
the components of CEM growth medium diluted 1,000-fold.
Peroxidase.
￿
MPO was purified from human leukocytes (19) and
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mined by guaiacol oxidation (21).
Lactobacilli.
￿
Hospital cultures of L. acidophilus obtained from
human vaginal swabs were initially tested for H202 production by
exposure to air of colonies which had been grown anaerobically
as surface colonies on agar containing horseradish peroxidase and
tetramethylbenzidine (18). Colonies of H20a-generating organisms
(LB*) formed a blue pigment, whereas organisms which did not
form H202 (LB-) remained white. LB+ and LB - cultures were
maintained by aerobic growth on HBT agar plates (01-478 Remel,
Lenexa, KS) at 37°C in a C02 incubator for no longer than 2 d.
Before the experiment, the organisms were transferred to peptone
yeastextract medium (22) containing 1% heat-inactivated FCS (Hy-
clone Laboratories, Logan, UT) and grown aerobically at 37°C
for approximately 6 h with tumbling for LB+ and 24 h in sta-
tionary tubes for LB - . The lactobacilli were washed twice and sus-
pended in 0.1 M sodium sulfate. H202 generation by LB' was de-
termined before each experiment by the scopoletin method (23).
MeasurementofKricidalActivity.
￿
The reaction mixtures described
in the legends to the figure and table were incubated in sterile
screwcap microtubes with sealing O-rings (4.3 x 10.8 mm, 1.5
ml capacity #75.692.005; Sarstedt, Inc., Princeton, NJ) for 30 min
at 37°C. The tubes were centrifuged at 2,940,g for 2 min to sedi-
ment the bacteria and 10 pl aliquots of the supernatant fraction
were addedto triplicate wells (48-well plate #3548; Costar, Cam-
bridge, MA) containing 2 x 105 CEM cells in 1 ml of CEM
grown medium per well. Following incubation at 37°C for 6 d
in a C02 incubator (5% C02-95% air), a 200 Etl aliquot was re-
moved for measurement of HIV P24 antigen by a solid phase
sandwich-type ELISA (Abbott Laboratories, Chicago, IL). If an
optical density of >2.000 was observed, the supernatant fraction
was diluted and remeasured. The data are expressed as the P24 an-
tigen level above background. A positive HIVP24 antigen cutoff
of 10pg/ml was used. In general, culture supernatant levels ofHIV
P24 antigen were either zero (<10 pg/ml), indicating no replica-
tion, or very high (>1,000,000 pg/ml), indicating unrestricted repli-
cation, with the level reached being related to the number of CEM
cells (2 x 101), the volume of the reaction mixture added to the
CEM cells (10 ul) and the growth period (6 d).
Results and Discussion
H202-generating L. acidophilus (LB') alone at a concen-
tration of 101 CFU/ml was viricidal to HIV in lactate buffer
pH 5.0 as measured by a decrease in viralreplication in CEM
cells (Fig. 1). When the LB' concentration was reduced to
a level where it was ineffective alone (2 x 105-5 x 106
CFU/ml), the addition of MPO and chloride resulted in a
return of HIV viricidal activity (Fig. 1).
The HIV viricidal activity of high concentrations of LB +
alone was variable, with complete loss ofHIV infectivity ob-
served in five of nine wells, giving a median P24 levelof <10
and a mean of 123 pg/ml (Table 1). An anti-HIV effect was
not seen when the LB' was heated at 100°C for 15 min or
was replaced by L. acidophilus which did not generate H202
(LB -). This toxic effect on HIV was inhibited by catalase,
but not by heated catalase, implicating H202. Table 1 also
demonstrates the viricidal effect of low levels of LB' com-
binedwith MPO and chloride, the requirement for each com-
ponent of the system, and the inhibition by heat-treatment
of LB +, by the substitution of LB - for LB + and by the ad-
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Figure 1.
￿
The viricidal effect ofH202-generating L. acidophilus on HIV
in the presence and absence of MPO and chloride. The reaction mixture
contained 4 x 10 -2 M sodium lactate buffer pH 5.0, 0.005% gelatin,
2 x 10 -2 M glucose, 7.7 x 10-2 M sodium sulfate, and 1,000
TCID50/ml HIV, either alone (A) or with LB* at the concentrations in-
dicated without (") or with 23 mU/ml MPO and 0.1 M sodium chloride
(0) in a final volume of0.5 ml. The results are the mean of3-12 determi-
nations.
dition of azide (which inhibits peroxidase) or catalase, but
not heated catalase or superoxide dismutase, again implicating
H202. Chloride could be replaced by iodide, bromide or
thiocyanate ions, LB+ could be replaced by reagent H202
and MPO couldbe replaced by EPO. However, chloride was
less effective with EPO than with MPO.
The inhibition of HIV infectivity was not due to direct
toxicity to the CEM cells. The evidence is as follows: (a) the
reaction mixture was diluted 100-fold on addition to the CEM
cells; (b) the CEM cells continue to metabolize and divide
at a normal rate as indicated by acid production and increase
in cell number; (c) identical results were observed when cata-
lase was used to stop the reaction before the addition of an
aliquot to the CEM cells; and (d) the toxicity of the peroxi-
dase system is known to be strongly inhibited by protein and
low mol wt components present in the CEM growth medium.
L. acidophilus has been detectedin the vagina ofmost normal
women with the level of H202-producing lactobacilli aver-
aging 8.4 x 106 organisms per ml in one study (18). Under
our in vitro conditions, the amount of H202 generated by
107 organisms was sufficient to inactivate HIV in the absence
of peroxidase, and when MPO and chloride were added, con-
centrations of LB+ as low as 2 x 105 CFU/ml were effec-
tive. Thus, lactobacilli appear to be present in the vagina in
adequate numbers to exert an antiviral effect. Peroxidase has
also been detected in human vaginal fluid (24). Ofthe halides,
chloride is present in cervical mucus in high concentration
(25) and iodide and thiocyanate are concentrated there fol-
lowing intravenous administration to humans (26). Theirpres-
ence in vaginal fluid would thus be anticipated. The pH em-
ployed here is approximately that ofvaginal fluid. Additional
studies are needed to evaluate the influence of potential in-
hibitors in vaginal fluid (catalase, protein, low mol wt-reducing
substances).Table 1.
￿
Properties of the LB+ -Dependent
Human Immunodeficiency Virus (HIV}Inhibitory System
The reaction mixture was as described in Fig. 1, except that the addi-
tions were: LB+ and LB- at the concentrations indicated; 23 mU/ml
MPO; 23 mU/ml EPO; 0.1 M sodium chloride; 10 -4 M sodium iodide;
10 -4 M sodium bromide; 10-4 M sodium thiocyanate; 10- 5 M H202;
10-4 M sodium azide; 5.8 hg/ml catalase (CTR bovine liver, 84,150
U/mg, [Worthington Biochem, Freehold, NJ] dialyzed before use); 10
Wg/ml superoxide dismutase (SOD, bovine erythrocyte, 3,150 U/mg,
[Sigma Chemical Co.]). The LB+ and catalase were heated for 15 min
at 100°C where indicated. The heated LB+ was collected by centrifu-
gation and resuspended in 0.1 M sodium sulfate to the required optical
density.Theresults areexpressed as the mean P24antigenlevelin pg/ml
andthe ratio of thenumber of samples in whichviral replication occurred
over the totalnumber of samples. Theresults arethe mean of 3-9deter-
minations.
We have concentrated on the destruction of cell-free HIV
HIV in semen is both cell-associated and free in seminal plasma
(27) and it is not clear which form is responsible for male
to female vaginal transmission. The infection of primates by
intravaginal infusion of cell-free HIV or SIV, however, has
been described (28, 29).
Our findings suggest that the presence and level of H202-
producing lactobacilli in vaginal fluid may affect the heter-
osexual transmission of HIV by the release of H202, which
can act either alone or in conjuction with a halide and perox-
idase ofleukocytic or uterine orgin to inactivate HIV Normal
individuals, or persons with sexually transmitted vaginal dis-
ease, in whom vaginal H202-producing lactobacilli are few
or absent, may thus be at greater risk of infection and, as
a corollary, may benefit from vaginal colonization with
H202-generating lactobacilli. The systemic treatment of
AIDS patients with orally-administered live lactobacilli has
been proposed (30). The presence of peroxidase in other lo-
cations, e.g., LPO in milk and saliva, MPO in neutrophils
and monocytes, EPO in eosinophils and extracellular MPO
or EPO in inflammatory loci containing degenerating or
stimulated phagocytes, raise the possibility that the peroxi-
dase system utilizing H202 formed by microorganisms,
phagocytes or soluble enzymes also contributes to the host
defense against HIV at other sites.
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Additions
HIV P24
antigen
No. with
HIV growth/
No. of samples
(Pg/ml)
None 1,202,604 9/9
LB+ (10'/ml) 123 4/9
LB' heated 2,063,677 3/3
LB' deleted, LB - added 1,982,759 3/3
Catalase added 162,754 8/9
Heated catalase added 198 5/9
LB' (106/ml) + MPO + C1 <10 0/12
Cl deleted 2,303,638 3/3
MPO deleted 4,368,805 3/3
LB+ deleted 3,760,265 3/3
LB+ heated 5,614,311 3/3
LB+ deleted, LB - added 3,685,807 3/3
Azide added 3,368,574 3/3
Catalase added 5,075,827 3/3
Heated catalase added <10 0/6
SOD added <10 0/6
Cl deleted, I added <10 0/6
C1 deleted, Br added <10 0/6
Cl deleted, SCN added <10 0/6
LB+ deleted, H202 added <10 0/6
LB+ (106/ml) + EPO + Cl 12,965 6/6
Cl deleted, I added <10 0/6
C1 deleted, Br added <10 0/6
Cl deleted, SCN added <10 0/6References
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